Yeast GMP Kinase Mutants Constitutively Express AMP Biosynthesis Genes by Phenocopying a Hypoxanthine-Guanine Phosphoribosyltransferase Defect

Corresponding author: Bertrand Daignan-Fornier, Institut de Biochimie et Génétique Cellulaires, 1, rue Camille Saint-Saëns, 33077 Bordeaux Cedex, France., b.daignan-fornier{at}ibgc.u-bordeaux2.fr (E-mail)

Communicating editor: A. G. HINNEBUSCH

We have characterized a new locus, BRA3, leading to deregulation of the yeast purine synthesis genes (ADE genes). We show that bra3 mutations are alleles of the GUK1 gene, which encodes GMP kinase. The bra3 mutants have a low GMP kinase activity, excrete purines in the medium, and show vegetative growth defects and resistance to purine base analogs. The bra3 locus also corresponds to the previously described pur5 locus. Several lines of evidence indicate that the decrease in GMP kinase activity in the bra3 mutants results in GMP accumulation and feedback inhibition of hypoxanthine-guanine phosphoribosyltransferase (HGPRT), encoded by the HPT1 gene. First, guk1 and hpt1 mutants share several phenotypes, such as adenine derepression, purine excretion, and 8-azaguanine resistance. Second, overexpression of HPT1 allows suppression of the deregulated phenotype of the guk1 mutants. Third, we show that purified yeast HGPRT is inhibited by GMP in vitro. Finally, incorporation of hypoxanthine into nucleotides is similarly diminished in hpt1 and guk1 mutants in vivo. We conclude that the decrease in GMP kinase activity in the guk1 mutants results in deregulation of the ADE gene expression by phenocopying a defect in HGPRT. The possible occurrence of a similar phenomenon in humans is discussed.

This article has been cited by other articles:

				D. Kowalski, L. Pendyala, B. Daignan-Fornier, S. B. Howell, and R.-Y. Huang Dysregulation of Purine Nucleotide Biosynthesis Pathways Modulates Cisplatin Cytotoxicity in Saccharomyces cerevisiae Mol. Pharmacol., October 1, 2008; 74(4): 1092 - 1100. [Abstract] [Full Text] [PDF]

				A. Breton, B. Pinson, F. Coulpier, M.-F. Giraud, A. Dautant, and B. Daignan-Fornier Lethal Accumulation of Guanylic Nucleotides in Saccharomyces cerevisiae HPT1-Deregulated Mutants Genetics, February 1, 2008; 178(2): 815 - 824. [Abstract] [Full Text] [PDF]

				H. Fang, W. Luo, J. Henkel, J. Barbieri, and N. Green A yeast assay probes the interaction between botulinum neurotoxin serotype B and its SNARE substrate PNAS, May 2, 2006; 103(18): 6958 - 6963. [Abstract] [Full Text] [PDF]

				M. Castellanos, D. B. Wilson, and M. L. Shuler A modular minimal cell model: Purine and pyrimidine transport and metabolism PNAS, April 27, 2004; 101(17): 6681 - 6686. [Abstract] [Full Text] [PDF]

				B. J. Beck, M. Huelsmeyer, S. Paul, and D. M. Downs A Mutation in the Essential Gene gmk (Encoding Guanlyate Kinase) Generates a Requirement for Adenine at Low Temperature in Salmonella enterica J. Bacteriol., November 15, 2003; 185(22): 6732 - 6735. [Abstract] [Full Text] [PDF]

				K. Rebora, C. Desmoucelles, F. Borne, B. Pinson, and B. Daignan-Fornier Yeast AMP Pathway Genes Respond to Adenine through Regulated Synthesis of a Metabolic Intermediate Mol. Cell. Biol., December 1, 2001; 21(23): 7901 - 7912. [Abstract] [Full Text] [PDF]

				M. Escobar-Henriques and B. Daignan-Fornier Transcriptional Regulation of the Yeast GMP Synthesis Pathway by Its End Products J. Biol. Chem., January 5, 2001; 276(2): 1523 - 1530. [Abstract] [Full Text] [PDF]

				R. J. Shaw, J. L. Wilson, K. T. Smith, and D. Reines Regulation of an IMP Dehydrogenase Gene and Its Overexpression in Drug-sensitive Transcription Elongation Mutants of Yeast J. Biol. Chem., August 24, 2001; 276(35): 32905 - 32916. [Abstract] [Full Text] [PDF]